First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
- 17 December 2009
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (2), 156-163
- https://doi.org/10.1016/j.ijantimicag.2009.10.008
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infectionsInternational Journal of Antimicrobial Agents, 2008
- Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsisCritical Care, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an updateJournal of Antimicrobial Chemotherapy, 2005
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004
- Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS TrialClinical Infectious Diseases, 2004
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*Critical Care Medicine, 2003
- Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsisThe American Journal of Medicine, 2003
- Inadequate Antimicrobial Treatment of InfectionsChest, 1999
- Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic modelAntimicrobial Agents and Chemotherapy, 1994